Name | Source | Ver | Description |
ACS Example Clopidogrel Codes | hl7.fhir.uv.vulcan-rwd#current | R4 | An example value set of codes for Clopidogrel for the Acute Coronary Syndrome use case. |
ACS Example Prasugrel Codes | hl7.fhir.uv.vulcan-rwd#current | R4 | An example value set of codes for Prasugrel for the Acute Coronary Syndrome use case. |
ACS Example Ticagrelor Codes | hl7.fhir.uv.vulcan-rwd#current | R4 | An example value set of codes for Ticagrelor for the Acute Coronary Syndrome use case. |
All NDC Products | hl7.fhir.us.spl#current | R4B | A value set that is all of the NDC codesystem, i.e. all NDC products |
Alternative nPEP Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the Alternative nPEP Supplied element |
COVID-19 Vaccine Codes | hl7.fhir.us.icsr-ae-reporting#current | R4 | CPT, CVX, NDC, and RxNorm codes for COVID-19 Vaccines |
Emtricitabine (FTC) 200mg Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the Emtricitabine (FTC) 200mg Supplied element |
FDA National Drug Code (NDC) | hl7.fhir.us.davinci-pdex#current | R4 | The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 360)). Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory which is updated daily. The information submitted as part of the listing process, the NDC number, and the NDC Directory are used in the implementation and enforcement of the Act. Users should note: Starting June 1, 2011, only drugs for which electronic listings (SPL) have been submitted to the FDA are included in the NDC Directory. Drugs for which listing information was last submitted to FDA on paper forms, prior to June 2009, are included on a separate file and will not be updated after June 2012. Information regarding the FDA published NDC Directory can be found [here](https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory) Users should note a few important items * The NDC Directory is updated daily. * The new NDC Directory contains ONLY information on final marketed drugs submitted to the FDA in SPL electronic listing files by labelers. * The NDC Directory does not contain all listed drugs. The new version includes the final marketed drugs which listing information were submitted electronically. It does not include animal drugs, blood products, or human drugs that are not in final marketed form, such as Active Pharmaceutical Ingredients(APIs), drugs for further processing, drugs manufactured exclusively for a private label distributor, or drugs that are marketed solely as part of a kit or combination product or inner layer of a multi-level packaged product not marketed individually. For more information about how certain kits or multi-level packaged drugs are addressed in the new NDC Directory, see the NDC Directory Package File definitions document. For the FDA Online Label Repository page and additional resources go to: [FDA Online Label Repository](https://labels.fda.gov/) |
Influenza Vaccine Codes | hl7.fhir.us.icsr-ae-reporting#current | R4 | CVX, NDC, and RxNorm codes for Influenza Vaccines |
Medications - example (IPS) | hl7.fhir.uv.ips#current | R4 | This value set provides an example of possible medication coded concepts. This value set will be removed in a future release and has been replaced with [medication-snomed-uv-ips](./ValueSet-medication-snomed-uv-ips.html). |
National Drug Code (NDC) Value Set | hl7.fhir.us.carin-bb#current | R4 | The Drug Listing Act of 1972 requires registered drug establishments to provide the Food and Drug Administration (FDA) with a current list of all drugs manufactured, prepared, propagated, compounded, or processed by it for commercial distribution. (See Section 510 of the Federal Food, Drug, and Cosmetic Act (Act) (21 U.S.C. § 360)). Drug products are identified and reported using a unique, three-segment number, called the National Drug Code (NDC), which serves as a universal product identifier for drugs. FDA publishes the listed NDC numbers and the information submitted as part of the listing information in the NDC Directory which is updated daily. The information submitted as part of the listing process, the NDC number, and the NDC Directory are used in the implementation and enforcement of the Act. Users should note: Starting June 1, 2011, only drugs for which electronic listings (SPL) have been submitted to FDA are included in the NDC Directory. Drugs for which listing information was last submitted to FDA on paper forms, prior to June 2009, are included on a separate file and will not be updated after June 2012. Information regarding the FDA published NDC Directory can be found [here](https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory) Users should note a few important items * The NDC Directory is updated daily. * The new NDC Directory contains ONLY information on final marketed drugs submitted to FDA in SPL electronic listing files by labelers. * The NDC Directory does not contain all listed drugs. The new version includes the final marketed drugs which listing information were submitted electronically. It does not include animal drugs, blood products, or human drugs that are not in final marketed form, such as Active Pharmaceutical Ingredients(APIs), drugs for further processing, drugs manufactured exclusively for a private label distributor, or drugs that are marketed solely as part of a kit or combination product or inner layer of a multi-level packaged product not marketed individually. For more information about how certain kits or multi-level packaged drugs are addressed in the new NDC Directory, see the NDC Directory Package File definitions document. For the FDA Online Label Repository page and additional resources go to: [FDA Online Label Repository](https://labels.fda.gov/) |
NDC or Compound Value Set | hl7.fhir.us.carin-bb#current | R4 | Values will be the NDC Codes when the Compound Code value is 0 or 1. When the Compound Code value = 2, the value will be the literal, ‘compound’ |
PCDE Plan Action | hl7.fhir.us.davinci-pcde#current | R4 | Codes describing interventions in a coverage transition document |
PCT GFE Item NDC Value Set | hl7.fhir.us.davinci-pct#current | R4 | The FDA published list of NDC codes for finished drug products |
Preferred nPEP Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the Preferred nPEP Supplied element |
RTPBC Prescribable Product Code Value Set | hl7.fhir.us.carin-rtpbc#1.0.0 | R4 | This value set includes codes used to specify prescribed medications in the US: RxNorm codes that specify drug name, strength and dose form (SBD, SCD, BPCK and GPCK term types) and NDC-11 codes (which represent specific packaged products). |
TAF 25mg / FTC 200mg Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the TAF 25mg / FTC 200mg Supplied element |
TDF 300mg / FTC 200mg Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the TDF 300mg / FTC 200mg Supplied element |
Tenofovir Alafenamide (TAF) 25 mg Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the Tenofovir Alafenamide (TAF) 25 mg Supplied element |
Tenofovir Disoproxil Fumarate (TDF) 300mg Supplied Codes | fhir.nachc.hiv-cds#current | R4 | Codes representing possible values for the Tenofovir Disoproxil Fumarate (TDF) 300mg Supplied element |
Vaccine National Drug Code (NDC) | fhir.argonaut.r2#1.0.0 | R2 | This value set includes all the Vaccine National Drug Codes (NDC). This source of this data is provided by the [CDC](https://www2a.cdc.gov/vaccines/iis/iisstandards/ndc_crosswalk.asp) |
X12 278 Requested Service Type | hl7.fhir.us.davinci-pas#current | R4 | This set of codes identifies what service is being requested. It is a combination of X12 Service Type codes, CPT (HCPCS I) and HCPCS II procedure code modifiers, ICD-9 Procedure codes, ICD-10 Procedure codes, and NDC Drug codes. NOTE: HCPCS Level 1 Codes are the CPT codes so either code system could be used to send the codes. When receiving the codes from an X12 system, the system returned will be HCPCS even if it was initially sent as a CPT code. |
Produced 08 Sep 2023